Evaluating TAB2, IKBKB, and IKBKG Gene Polymorphisms and Serum Protein Levels and Their Association with Age-Related Macular Degeneration and Its Treatment Efficiency
2024

Gene Variants and Their Role in Age-Related Macular Degeneration

Sample size: 961 publication 10 minutes Evidence: moderate

Author Information

Author(s): Vilkeviciute Alvita, Pileckaite Enrika, Bruzaite Akvile, Cebatoriene Dzastina, Gedvilaite-Vaicechauskiene Greta, Kriauciuniene Loresa, Zaliuniene Dalia, Liutkeviciene Rasa

Primary Institution: Lithuanian University of Health Sciences

Hypothesis

This study investigates the association of TAB2, IKBKB, and IKBKG gene polymorphisms with age-related macular degeneration (AMD) and treatment response.

Conclusion

The study identified the TAB2 rs237025 allele A as a significant risk factor for both early and exudative AMD, with gender-specific associations observed in females.

Supporting Evidence

  • The TAB2 rs237025 allele A was identified as a risk factor for early and exudative AMD.
  • Gender-specific associations were observed in females with exudative AMD.
  • The A allele of IKBKB rs13278372 was associated with a worse response to anti-VEGF treatment.
  • IKBKG rs2472395 was found to be protective for early AMD in males and exudative AMD in females.
  • Lower IKBKG protein levels were associated with exudative AMD.

Takeaway

This study looked at how certain genes might affect the risk of getting a vision problem called AMD and how well treatments work for it.

Methodology

The study used a case-control design with genotyping of selected SNPs conducted using RT-PCR and analyzed data with IBM SPSS Statistics.

Potential Biases

Potential for Type II errors due to conservative Bonferroni correction for multiple comparisons.

Limitations

The study's focus on a single Lithuanian population limits generalizability to other populations.

Participant Demographics

Participants included 961 individuals divided into control, early AMD, and exudative AMD groups.

Statistical Information

P-Value

0.041

Confidence Interval

95% CI: 0.145–0.961

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/medicina60122072

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication